Dry Eye Treatment With Artificial Tears
Launched by ASTON UNIVERSITY · Apr 15, 2015
Trial Information
Current as of September 17, 2025
Completed
Keywords
ClinConnect Summary
The efficacy of different classes of artificial tears (non-pharmaceutical) will be examined in patients that report dry eyes by prescribing each category of treatment \[0.40% Sodium Hyaluronate (Clinitas Soothe), 0.15% Sodium Hyaluronate (Hyabak), 0.25% Carboxymethylcellulose, electrolyte balanced (Theratears), and Phospholipid liposomal spray (Tears Again)\] for a month in turn following a short wash-out period and to examine their tear film and ocular surface after each one.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subjective symptoms indicative of dry eye
- Exclusion Criteria:
- • Diabetes
- • Sjögren's Syndrome
- • recent ocular infection
- • hay fever
- • used any eye drops or ocular medications,
- • were currently on medications known to affect the eyes
- • wore contact lenses
- • were pregnant.
About Aston University
Aston University is a leading research institution based in Birmingham, UK, renowned for its commitment to advancing knowledge and innovation across various disciplines, including health sciences. As a clinical trial sponsor, Aston University leverages its strong academic foundation and interdisciplinary expertise to conduct rigorous and ethical research aimed at improving patient outcomes and healthcare practices. The university fosters collaboration with healthcare professionals, industry partners, and regulatory bodies to ensure that its clinical trials adhere to the highest standards of scientific integrity and compliance, ultimately contributing to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Thornton, Cleveleys, United Kingdom
Patients applied
Trial Officials
James S Wolffsohn, BSc PhD
Principal Investigator
Aston University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials